20
Alembic Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CANDESARTAN CILEXETIL USP (CND PROCESS), with a corresponding US DMF Number 30240.
Remarkably, this DMF maintains an Active status since its submission on February 19, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 01, 2016, and payment made on February 10, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II